ArticleJournal of central nervous system disease2024

Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study.

Christoph Friedli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.